Cargando…
Cost-effectiveness analysis has to consider all available evidence when informing inputs
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993143/ https://www.ncbi.nlm.nih.gov/pubmed/32961079 http://dx.doi.org/10.1080/21645515.2020.1799670 |
| _version_ | 1783669507548512256 |
|---|---|
| author | Alvarez, Fabián P. Petitjean, Audrey Nealon, Joshua Hollingsworth, Rosalind López-Belmonte, Juan Luis |
| author_facet | Alvarez, Fabián P. Petitjean, Audrey Nealon, Joshua Hollingsworth, Rosalind López-Belmonte, Juan Luis |
| author_sort | Alvarez, Fabián P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7993143 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79931432021-03-31 Cost-effectiveness analysis has to consider all available evidence when informing inputs Alvarez, Fabián P. Petitjean, Audrey Nealon, Joshua Hollingsworth, Rosalind López-Belmonte, Juan Luis Hum Vaccin Immunother Letter Taylor & Francis 2020-09-22 /pmc/articles/PMC7993143/ /pubmed/32961079 http://dx.doi.org/10.1080/21645515.2020.1799670 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
| spellingShingle | Letter Alvarez, Fabián P. Petitjean, Audrey Nealon, Joshua Hollingsworth, Rosalind López-Belmonte, Juan Luis Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title | Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title_full | Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title_fullStr | Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title_full_unstemmed | Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title_short | Cost-effectiveness analysis has to consider all available evidence when informing inputs |
| title_sort | cost-effectiveness analysis has to consider all available evidence when informing inputs |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993143/ https://www.ncbi.nlm.nih.gov/pubmed/32961079 http://dx.doi.org/10.1080/21645515.2020.1799670 |
| work_keys_str_mv | AT alvarezfabianp costeffectivenessanalysishastoconsiderallavailableevidencewheninforminginputs AT petitjeanaudrey costeffectivenessanalysishastoconsiderallavailableevidencewheninforminginputs AT nealonjoshua costeffectivenessanalysishastoconsiderallavailableevidencewheninforminginputs AT hollingsworthrosalind costeffectivenessanalysishastoconsiderallavailableevidencewheninforminginputs AT lopezbelmontejuanluis costeffectivenessanalysishastoconsiderallavailableevidencewheninforminginputs |